Johnson & Johnson chief executive officer Alex Gorsky said Wednesday that the company's McNeil Consumer Healthcare unit was "on track" to talk with the Food and Drug Administration by year's end about resuming production at its troubled Fort Washington plant.
In a brief interview after speaking at the Wharton Leadership Conference at the University of Pennsylvania, Gorsky also said he wants to keep the consumer division of the health-care giant, which includes McNeil, despite some financial analysts' suggestion that it be divested.
"Absolutely," Gorsky said, when asked about keeping the consumer division, which has such brands as Band-Aids, Listerine and Tylenol. "The consumer part of Johnson & Johnson is a huge historical piece. I think the whole idea of consumerism in health care going forward is going to be an important component and will touch everything."